Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer

MLA

Yelisudan Mulati, et al. “Establishment of a Prognostic Risk Prediction Model Incorporating Disulfidptosis-Related LncRNA for Patients with Prostate Cancer.” BMC Cancer, vol. 24, no. 1, Jan. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12885-023-11778-2.

APA

Yelisudan Mulati, Cong Lai, Jiawen Luo, Jintao Hu, Xiaoting Xu, Degeng Kong, Yunfei Xiao, Cheng Liu, & Kewei Xu. (2024). Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer. BMC Cancer, 24(1), 1–12. https://doi.org/10.1186/s12885-023-11778-2

Chicago

Yelisudan Mulati, Cong Lai, Jiawen Luo, Jintao Hu, Xiaoting Xu, Degeng Kong, Yunfei Xiao, Cheng Liu, and Kewei Xu. 2024. “Establishment of a Prognostic Risk Prediction Model Incorporating Disulfidptosis-Related LncRNA for Patients with Prostate Cancer.” BMC Cancer 24 (1): 1–12. doi:10.1186/s12885-023-11778-2.